Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yusuke Matsunaga

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cellsYusuke Matsunaga, Daiki Fukuma, Shinya Hirata, et al.
Stem Cells (Dayton, Ohio)|May 6, 2009
Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cellsSatoru Senju, Miwa Haruta, Yusuke Matsunaga, et al.
Plos One|July 5, 2013
Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft modelsChihiro Koba, Miwa Haruta, Yusuke Matsunaga, et al.
Oncoimmunology|May 7, 2014
Application of iPS cell-derived macrophages to cancer therapySatoru Senju, Chihiro Koba, Miwa Haruta, et al.
Nephron|August 16, 2023
Association between Physical Frailty and Sleep Disturbances among Patients on Hemodialysis: A Cross-Sectional StudyShun Yoshikoshi, Shohei Yamamoto, Yuta Suzuki, et al.
Journal of Nephrology|January 6, 2022
Impact of the COVID-19 pandemic on depressive symptoms in Japanese patients undergoing hemodialysisJuri Uchida, Shun Yoshikoshi, Takuya Nakajima, et al.
Therapeutic Drug Monitoring|January 19, 2006
Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patientsYusuke Matsunaga, Akinobu Hamada, Isamu Okamoto, et al.
Journal of Nephrology|September 3, 2025
Effects of electrical muscle stimulation during hemodialysis in older patients with frailty: a crossover randomized controlled trialYuta Suzuki, Kentaro Kamiya, Keika Hoshi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 30, 2019
Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis PatientsYuta Suzuki, Ryota Matsuzawa, Kentaro Kamiya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cellsSatoshi Fukushima, Shinya Hirata, Yutaka Motomura, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cellsYusuke Matsunaga, Daiki Fukuma, Shinya Hirata, et al.
Stem Cells (Dayton, Ohio)|May 6, 2009
Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cellsSatoru Senju, Miwa Haruta, Yusuke Matsunaga, et al.
Plos One|July 5, 2013
Therapeutic effect of human iPS-cell-derived myeloid cells expressing IFN-β against peritoneally disseminated cancer in xenograft modelsChihiro Koba, Miwa Haruta, Yusuke Matsunaga, et al.
Oncoimmunology|May 7, 2014
Application of iPS cell-derived macrophages to cancer therapySatoru Senju, Chihiro Koba, Miwa Haruta, et al.
Nephron|August 16, 2023
Association between Physical Frailty and Sleep Disturbances among Patients on Hemodialysis: A Cross-Sectional StudyShun Yoshikoshi, Shohei Yamamoto, Yuta Suzuki, et al.
Journal of Nephrology|January 6, 2022
Impact of the COVID-19 pandemic on depressive symptoms in Japanese patients undergoing hemodialysisJuri Uchida, Shun Yoshikoshi, Takuya Nakajima, et al.
Therapeutic Drug Monitoring|January 19, 2006
Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patientsYusuke Matsunaga, Akinobu Hamada, Isamu Okamoto, et al.
Journal of Nephrology|September 3, 2025
Effects of electrical muscle stimulation during hemodialysis in older patients with frailty: a crossover randomized controlled trialYuta Suzuki, Kentaro Kamiya, Keika Hoshi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 30, 2019
Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis PatientsYuta Suzuki, Ryota Matsuzawa, Kentaro Kamiya, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 27, 2009
Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cellsSatoshi Fukushima, Shinya Hirata, Yutaka Motomura, et al.
Pageof 3